CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation

Manesh R. Patel, W. Frank Peacock, Sally Tamayo, Nicholas Sicignano, Kathleen P. Hopf, Zhong Yuan

Clin Exp Emerg Med. 2018;5(1):43-50. Published online 2018 March 30 DOI: https://doi.org/10.15441/ceem.17.216

Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation

Manesh R. Patel, W. Frank Peacock, Sally Tamayo, Nicholas Sicignano, Kathleen P. Hopf, Zhong Yuan

Clinical and Experimental Emergency Medicine. 2018;5(1):43-50

Link1

Link2 Link3

MAJOR BLEEDING AMONG RIVAROXABAN USERS WITH NONVALVULAR ATRIAL FIBRILLATION AND DIABETES

Manesh R. Patel, Sally Tamayo, Zhong Yuan, Nicholas Sicignano, Kathleen Hopf, Frank Peacock

Journal of the American College of Cardiology. 2016;67(13):733

Link1 Link2

Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus

W. Frank Peacock, Sally Tamayo, Nicholas Sicignano, Kathleen P. Hopf, Zhong Yuan, Manesh Patel

The American Journal of Cardiology. 2017;119(5):753-759

Link1 Link2

IMPACT OF RENAL FUNCTION ON ISCHEMIC STROKE AND MAJOR BLEEDING RATES IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH WARFARIN AND RIVAROXABAN

Winnie Nelson, François Laliberté, Kip Brown, Patrick Lefebvre, Jeffrey Schein

Journal of the American College of Cardiology. 2016;67(13):891

Link1 Link2

CHA 2 DS 2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban

W. Frank Peacock, Sally Tamayo, Manesh Patel, Nicholas Sicignano, Kathleen P. Hopf, Zhong Yuan

Annals of Emergency Medicine. 2017;69(5):541-550.e1

Link1 Link2

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Indian Heart Journal. 2012;64(1):110-111

Link1 Link2

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

Alison Evans, Miranda Davies, Vicki Osborne, Debabrata Roy, Saad Shakir

PLOS ONE. 2020;15(10):e0240489

Link1

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

P.C. Netzler

Yearbook of Cardiology. 2012;2012:490-492

Link1 Link2

Cost-Effectiveness Of Rivaroxaban Versus Warfarin For Treatment Of Nonvalvular Atrial Fibrillation In Patients With Worsening Renal Function

J Salcedo, JW, Hay, J Lam

Value in Health. 2018;21:S61

Link1 Link2

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban

Sally Tamayo, W. Frank Peacock, Manesh Patel, Nicholas Sicignano, Kathleen P. Hopf, Larry E. Fields, Troy Sarich, Shujian Wu, Daniel Yannicelli, Zhong Yuan

Clinical Cardiology. 2015;38(2):63-68

Link1 Link2 Link3 Link4

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Exp Emerg Med has participated in CrossRef Text and Data Mining service since October 29, 2014.